Literature DB >> 3013946

Abnormal steroid excretion in gestational trophoblastic disease complicated by ovarian theca-lutein cysts.

B R Bevan, M Savvas, J M Jenkins, K Baker, G W Pennington, N F Taylor.   

Abstract

Serum and urine steroids were examined in two subjects with trophoblastic disease accompanied by large ovarian theca-lutein cysts and compared with those from 10 patients with trophoblastic disease but without palpable cysts. In the patients without cysts normal values were obtained for serum oestradiol, progesterone, 17 alpha-hydroxyprogesterone and androstenedione, and for urinary total oestrogens, pregnanediol, pregnanetriol, and 17-oxosteroids. Nineteen urinary steroid metabolites, quantified by capillary gas-liquid chromatography, were either within reference limits or marginally raised. In several cases relatively minor increases in serum testosterone and cortisol and urinary free cortisol were observed. In contrast, the subjects with cysts showed pronounced excesses of androgen metabolites, 17 alpha-hydroxypregnenolone, pregnanediol, and pregnanetriol, and both exhibited a similar pattern of unusual additional metabolites. The profiles superficially resembled those seen in 21-hydroxylase deficiency adrenogenital syndrome, but there were important discrepancies reflecting known differences in ovarian and adrenal steroid metabolism. Chemotherapy led to decline of human chorionic gonadotrophin concentrations, regression of the cysts, and return to normal of the steroid profile. Excess steroids in the patients with cysts may have originated in the ovary rather than in the trophoblastic tissue.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013946      PMCID: PMC499973          DOI: 10.1136/jcp.39.6.627

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

1.  Excretion of pregnanetriol in a case of hydatidiform mole associated with ovarian theca lutein cysts.

Authors:  S R Stitch; M J Levell; R E Oakey; J S Scott
Journal:  Lancet       Date:  1966-06-18       Impact factor: 79.321

2.  Steroidogenesis in a case of hydatidiform mole.

Authors:  J R Coutts; M C Macnaughton; P E Ross; J Walker
Journal:  J Endocrinol       Date:  1969-07       Impact factor: 4.286

3.  A critical appraisal of a method fo estimating urinary 17-oxosteroids and total 17-oxogenic steroids. A memorandum prepared at the request of the clinical Endocrinology Committee of the Medical Research Council.

Authors:  C H Gray; D N Baron; R V Brooks; V H James
Journal:  Lancet       Date:  1969-01-18       Impact factor: 79.321

4.  Improved estriol determination in a continuous flow system.

Authors:  M Lever; J C Powell; S M Peace
Journal:  Biochem Med       Date:  1973-10

5.  Plasma testosterone levels in trophoblastic disease and the effects of oophorectomy and chemotherapy.

Authors:  N A Samaan; J P Smith; F N Rutledge; J M Barcellona
Journal:  J Clin Endocrinol Metab       Date:  1972-03       Impact factor: 5.958

6.  Serum progesterone and serum chorionic gonadotrophin in hydatidiform mole and choriocarcinoma.

Authors:  E S Teoh; N P Das; M Y Dawood; S S Ratnam
Journal:  Acta Endocrinol (Copenh)       Date:  1972-08

7.  Progesterone synthesis in the pure trophoblasts of human choriocarcinoma.

Authors:  W Y Huang; R A Pattillo; E Delfs; R F Mattingly
Journal:  Steroids       Date:  1969-12       Impact factor: 2.668

Review 8.  Hormonal changes in pathological pregnancy.

Authors:  H A van Leusden
Journal:  Vitam Horm       Date:  1972       Impact factor: 3.421

9.  The use of steroid profiling in the resolution of pregnenolone metabolites from porcine testicular preparations.

Authors:  T K Kwan; N F Taylor; D B Gower
Journal:  J Chromatogr       Date:  1984-09-28

10.  Serum estradiol-17beta and serum human chorionic gonadotropin in patients with hydatidiform moles.

Authors:  M Y Dawood; S S Ratnam; E S Teoh
Journal:  Am J Obstet Gynecol       Date:  1974-08-01       Impact factor: 8.661

View more
  4 in total

1.  5 alpha-reductase deficiency without hypospadias.

Authors:  W K Ng; N F Taylor; I A Hughes; J Taylor; P G Ransley; D B Grant
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

2.  Lesch-Nyhan syndrome: growth delay, testicular atrophy and a partial failure of the 11 beta-hydroxylation of steroids.

Authors:  R W Watts; R A Harkness; E Spellacy; N F Taylor
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

3.  Reference intervals for the urinary steroid metabolome: The impact of sex, age, day and night time on human adult steroidogenesis.

Authors:  Daniel Ackermann; Michael Groessl; Menno Pruijm; Belen Ponte; Geneviève Escher; Claudia H d'Uscio; Idris Guessous; Georg Ehret; Antoinette Pechère-Bertschi; Pierre-Yves Martin; Michel Burnier; Bernhard Dick; Bruno Vogt; Murielle Bochud; Valentin Rousson; Nasser A Dhayat
Journal:  PLoS One       Date:  2019-03-29       Impact factor: 3.240

4.  RAPIDLY PROGRESSIVE AND SEVERE HIRSUTISM FROM HYPERREACTIO LUTEINALIS WITHIN A BACKGROUND OF POLYCYSTIC OVARY SYNDROME.

Authors:  Hannah Miriam Mathew; Christopher Wang Lee; Shirin Haddady
Journal:  AACE Clin Case Rep       Date:  2018-11-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.